Aura Biosciences, Inc.·4

Jun 18, 4:10 PM ET

Johnson David Michael 4

4 · Aura Biosciences, Inc. · Filed Jun 18, 2025

Insider Transaction Report

Form 4
Period: 2025-06-17
Transactions
  • Award

    Stock Option (Right to Buy)

    2025-06-17+17,00017,000 total
    Exercise: $6.18Exp: 2035-06-17Common Stock (17,000 underlying)
  • Award

    Common Stock

    2025-06-17+13,000179,167 total
Holdings
  • Common Stock

    (indirect: By Velocity Capital Management)
    139,672
  • Common Stock

    (indirect: By Trust)
    75,000
  • Common Stock

    (indirect: By Trust)
    75,000
Footnotes (5)
  • [F1]These shares were acquired pursuant to a restricted stock unit ("RSU") award under the Issuer's 2021 Stock Option and Incentive Plan. Each RSU represents the right to receive one share of the Issuer's Common Stock. These RSUs vest in full upon the earlier to occur of (a) June 17, 2026 or (b) the next annual meeting of the Issuer's stockholders, subject to the Reporting Person's continued service as of such vesting date.
  • [F2]The shares are held by the NEJ09 IRREVOCABLE TRUST dated December 24, 2020, of which the Reporting Person is a trustee.
  • [F3]The shares are held by the NEJ12 IRREVOCABLE TRUST dated December 24, 2020, of which the Reporting Person is a trustee.
  • [F4]Velosity Capital Management LLC is an entity that the Reporting Person is the sole member of.
  • [F5]This stock option will vest and become exercisable in full upon the earlier to occur of (a) June 17, 2026 or (b) the next annual meeting of the Issuer's stockholders, subject to the Reporting Person's continued service as of such vesting date.

Documents

1 file
  • 4
    ownership.xmlPrimary

    4